Understanding how faulty signaling causes Cushing's syndrome
Defective PKA Signaling in Cushing's Syndrome
This study is looking into how certain changes in your body's signaling can lead to Cushing's syndrome, which causes too much cortisol, and it hopes to find new ways to help treat the condition better for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10905993 on NIH RePORTER |
What this research studies
This research investigates the underlying molecular mechanisms of Cushing's syndrome, a condition where the adrenal glands produce excessive cortisol. It focuses on the role of defective cAMP signaling in the adrenal cortex, particularly how mutations in protein kinase A (PKA) contribute to the disease. By analyzing genetic mutations and their effects on cellular signaling, the research aims to uncover potential therapeutic targets. Patients may benefit from insights that could lead to more effective treatments for managing their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Cushing's syndrome, particularly those with identified mutations in the PKA gene.
Not a fit: Patients without Cushing's syndrome or those whose condition is not linked to PKA mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients with Cushing's syndrome.
How similar studies have performed: Previous research has shown promising results in understanding similar signaling pathways in other endocrine disorders, suggesting potential for success in this area as well.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Scott, John D — University of Washington
- Study coordinator: Scott, John D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.